Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives

Glioblastoma, the most common, aggressive brain tumor, ranks among the least curable cancers—owing to its strong tendency for intracranial dissemination, high proliferation potential, and inherent tumor resistance to radiation and chemotherapy. Current glioblastoma treatment strategies are further h...

Descripción completa

Detalles Bibliográficos
Autores principales: Raucher, Drazen, Dragojevic, Sonja, Ryu, Jungsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304427/
https://www.ncbi.nlm.nih.gov/pubmed/30619758
http://dx.doi.org/10.3389/fonc.2018.00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304427/
https://www.ncbi.nlm.nih.gov/pubmed/30619758
http://dx.doi.org/10.3389/fonc.2018.00624

Ejemplares similares